Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…
Sell
40
IBRN Quote, Financials, Valuation and Earnings
Last price:
$22.02
Seasonality move
:
-2.76%
Day range:
$21.81 - $21.81
52-week range:
$17.86 - $28.74
Dividend yield:
0.46%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
130
Avg. volume:
1.3K
1-year change:
-6.56%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IBRN
iShares Neuroscience and Healthcare ETF
|
$21.81 | -- | -- | -- | $0.10 | 0.46% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$29.69 | -- | -- | -- | $0.15 | 1.37% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$36.16 | -- | -- | -- | $0.03 | 0.07% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$78.77 | -- | -- | -- | $0.01 | 0.18% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | 0.871 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 1.019 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.485 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.543 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
iShares Neuroscience and Healthcare ETF vs. Competitors
-
Which has Higher Returns IBRN or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to iShares Neuroscience and Healthcare ETF's net margin of --. iShares Neuroscience and Healthcare ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBRNiShares Neuroscience and Healthcare ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About IBRN or HART?
iShares Neuroscience and Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Neuroscience and Healthcare ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe iShares Neuroscience and Healthcare ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBRNiShares Neuroscience and Healthcare ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is IBRN or HART More Risky?
iShares Neuroscience and Healthcare ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IBRN or HART?
iShares Neuroscience and Healthcare ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.46%. NYLI Healthy Hearts ETF offers a yield of 1.37% to investors and pays a quarterly dividend of $0.15 per share. iShares Neuroscience and Healthcare ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBRN or HART?
iShares Neuroscience and Healthcare ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. iShares Neuroscience and Healthcare ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, iShares Neuroscience and Healthcare ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Neuroscience and Healthcare ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBRNiShares Neuroscience and Healthcare ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns IBRN or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to iShares Neuroscience and Healthcare ETF's net margin of --. iShares Neuroscience and Healthcare ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBRNiShares Neuroscience and Healthcare ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About IBRN or PTH?
iShares Neuroscience and Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Neuroscience and Healthcare ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe iShares Neuroscience and Healthcare ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBRNiShares Neuroscience and Healthcare ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is IBRN or PTH More Risky?
iShares Neuroscience and Healthcare ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.925, suggesting its less volatile than the S&P 500 by 7.464%.
-
Which is a Better Dividend Stock IBRN or PTH?
iShares Neuroscience and Healthcare ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.46%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. iShares Neuroscience and Healthcare ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBRN or PTH?
iShares Neuroscience and Healthcare ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. iShares Neuroscience and Healthcare ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, iShares Neuroscience and Healthcare ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Neuroscience and Healthcare ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBRNiShares Neuroscience and Healthcare ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns IBRN or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to iShares Neuroscience and Healthcare ETF's net margin of --. iShares Neuroscience and Healthcare ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBRNiShares Neuroscience and Healthcare ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About IBRN or XBI?
iShares Neuroscience and Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Neuroscience and Healthcare ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe iShares Neuroscience and Healthcare ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBRNiShares Neuroscience and Healthcare ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is IBRN or XBI More Risky?
iShares Neuroscience and Healthcare ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.396%.
-
Which is a Better Dividend Stock IBRN or XBI?
iShares Neuroscience and Healthcare ETF has a quarterly dividend of $0.10 per share corresponding to a yield of 0.46%. SPDR S&P Biotech ETF offers a yield of 0.18% to investors and pays a quarterly dividend of $0.01 per share. iShares Neuroscience and Healthcare ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBRN or XBI?
iShares Neuroscience and Healthcare ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. iShares Neuroscience and Healthcare ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, iShares Neuroscience and Healthcare ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Neuroscience and Healthcare ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBRNiShares Neuroscience and Healthcare ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
10
EXOD alert for May 29
Exodus Movement [EXOD] is up 17.31% over the past day.
Buy
80
SBET alert for May 29
SharpLink Gaming [SBET] is up 181.07% over the past day.
Buy
100
BOX alert for May 29
Box [BOX] is up 1.38% over the past day.
